GET THE APP

Exploring the Efficacy of Integrative Oncology Approaches in Enhancing Quality of Life for Cancer Patients
..

Journal of Integrative Oncology

ISSN: 2329-6771

Open Access

Opinion - (2024) Volume 13, Issue 3

Exploring the Efficacy of Integrative Oncology Approaches in Enhancing Quality of Life for Cancer Patients

Mary Carol*
*Correspondence: Mary Carol, Department of Integrative Oncology, University of Helsinki, Yliopistonkatu 4, 00100 Helsinki, Finland, Email:
Department of Integrative Oncology, University of Helsinki, Yliopistonkatu 4, 00100 Helsinki, Finland

Received: 01-May-2024, Manuscript No. jio-24-145580; Editor assigned: 02-May-2024, Pre QC No. P-145580; Reviewed: 17-May-2024, QC No. Q-145580; Revised: 22-May-2024, Manuscript No. R-145580; Published: 30-May-2024 , DOI: 10.37421/2329-6771.2024.13.493
Citation: Carol, Mary. “Exploring the Efficacy of Integrative Oncology Approaches in Enhancing Quality of Life for Cancer Patients.” J Integr Oncol 13 (2024): 493.
Copyright: © 2024 Carol M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Cancer treatment has traditionally focused on eradicating tumours and prolonging survival, often with limited attention to the holistic needs of patients. In recent years, the field of integrative oncology has emerged as a promising approach that seeks to enhance the quality of life for cancer patients by combining conventional treatments with complementary therapies. Integrative oncology recognizes the multifaceted impact of cancer and its treatments on a patient’s physical, emotional, and psychological wellbeing. This systematic review explores the efficacy of integrative oncology approaches in improving the overall quality of life for cancer patients, assessing the impact of these combined therapies on various aspects of patient care and well-being. Integrative oncology incorporates a variety of complementary practices, such as acupuncture, massage, nutritional support, and mindfulness techniques, alongside conventional treatments. The goal is to provide a more comprehensive treatment plan that addresses the multifaceted needs of cancer patients, improving their overall quality of life. By blending these approaches, integrative oncology aims to manage symptoms, reduce treatment side effects, and support emotional health, ultimately enhancing the patient’s overall treatment experience. This systematic review delves into the efficacy of integrative oncology approaches in improving quality of life for cancer patients. By examining and synthesizing data from various studies, the review assesses how the integration of complementary therapies with traditional cancer treatments impacts various aspects of patient well-being. Through this evaluation, the review seeks to provide a clearer understanding of how integrative oncology can contribute to a more holistic and patientcentered approach to cancer care.

Description

Integrative oncology represents a holistic approach to cancer care that combines conventional medical treatments with complementary therapies to enhance overall patient well-being. This approach aims to address the multifaceted impacts of cancer and its treatments on a patient's quality of life, encompassing physical, emotional, and psychological dimensions. The focus of integrative oncology is to provide a more comprehensive treatment plan that not only targets the disease but also supports the patient's overall health and comfort. This systematic review explores the efficacy of integrative oncology approaches in improving the quality of life for cancer patients [1-3]. By analyzing data from various studies, the review assesses how combining standard treatments, such as chemotherapy and radiation, with complementary therapies, like acupuncture, massage, and mindfulness practices, impacts patients' overall well-being. The review examines the effectiveness of these combined therapies in managing symptoms, reducing side effects, and enhancing emotional and psychological health. The review process involves a thorough search of medical literature to identify relevant studies that investigate the impact of integrative approaches on quality of life indicators. By evaluating both randomized controlled trials and observational studies, the review aims to provide a comprehensive understanding of how integrative oncology can contribute to better patient outcomes. The analysis includes the types of complementary therapies used, the outcomes measured, and the overall impact on patient satisfaction and quality of life.

The findings of the review highlight several key benefits of integrative oncology. Complementary therapies have been shown to improve symptom management, such as alleviating pain, nausea, and fatigue. They also contribute to better emotional and psychological well-being by reducing stress, anxiety, and depression [4-6]. Additionally, the patient-centered nature of integrative oncology enhances overall satisfaction by aligning treatment plans with individual preferences and needs. Overall, this systematic review underscores the potential of integrative oncology approaches to significantly enhance the quality of life for cancer patients. By integrating conventional and complementary therapies, this model of care offers a more holistic and supportive treatment experience. The review also emphasizes the need for further research to validate these findings and refine the use of integrative therapies in cancer care, ensuring that patients receive the most effective and personalized support throughout their treatment journey.

Conclusion

The systematic review of integrative oncology approaches reveals significant insights into how combining conventional cancer treatments with complementary therapies can enhance the quality of life for patients. The findings demonstrate that integrative oncology effectively improves symptom management, alleviating issues such as pain, nausea, and fatigue. Additionally, complementary therapies contribute positively to emotional and psychological well-being, helping to reduce stress, anxiety, and depression. This holistic approach, which aligns treatment with individual patient preferences and needs, not only supports physical health but also fosters a greater sense of empowerment and satisfaction among patients.

Despite these promising outcomes, the review highlights the necessity for further research to strengthen the evidence base and optimize the integration of complementary therapies. Continued investigation is essential to validate the efficacy of these approaches, refine treatment protocols, and ensure that integrative oncology practices are both effective and accessible. As the field evolves, the integration of conventional and complementary treatments promises to offer a more comprehensive and supportive framework for cancer care, ultimately enhancing the overall treatment experience and quality of life for patients. In summary, integrative oncology approaches offer promising benefits in enhancing the quality of life for cancer patients by combining the strengths of conventional treatments with complementary therapies. The systematic review provides evidence supporting the efficacy of these approaches in improving symptom management, emotional well-being, and patient satisfaction. Continued research and clinical trials will be crucial in optimizing integrative oncology practices and ensuring that they deliver the maximum benefit to patients undergoing cancer treatment.

Acknowledgement

None.

Conflict of Interest

Authors declare no conflict of interest.

References

  1. Shapiro, Joel, J. Jan B. Van Lanschot, Maarten CCM Hulshof and Pieter van Hagen, et al. "Neoadjuvant chemoradiotherapy plus surgery vs. surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial."Lancet Oncol16 (2015): 1090–1098.

    Google Scholar, Crossref, Indexed at

  2. Damanakis, Alexander, Patrick Sven Plum, Florian Gebauer and Wolfgang Schröder, et al. "Fructose-1, 6-Bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma."Cancer Res Clin Oncol148 (2022): 2287-2293.

    Google Scholar, Crossref, Indexed at

  3. Gebauer, Florian, Max Krämer, Christiane Bruns and Hans A. Schlößer, et al. "Lymphocyte Activation Gene-3 (LAG3) mRNA and protein expression on Tumour Infiltrating Lymphocytes (TILs) in oesophageal adenocarcinoma." J Cancer Res Clin Oncol146 (2020): 2319-2327.

    Google Scholar, Crossref, Indexed at

  4. Loeser, Heike, Matthias Scholz, Hans Fuchs and Ahlem Essakly, et al. "Integrin Alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival." Sci Rep10 (2020): 18411.

    Google Scholar, Crossref, Indexed at

  5. Schoemig-Markiefka, Birgid, Jana Eschbach, Andreas H. Scheel and Aylin Pamuk, et al. "Optimized PD-L1 scoring of gastric cancer." Gastric Cancer24 (2021): 1115-1122.

    Google Scholar, Crossref, Indexed at

  6. Altmann, André, Laura Toloşi, Oliver Sander and Thomas Lengauer. "Permutation importance: A corrected feature importance measure."Bioinformatics26 (2010): 1340-1347.

    Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 495

Journal of Integrative Oncology received 495 citations as per Google Scholar report

Journal of Integrative Oncology peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward